ThinkCyte, a biotechnology company pioneering novel artificial intelligence (AI)-based cell analysis and sorting instruments, ...

The U.S. Food and Drug Administration (FDA) has accepted for review Biologics License Applications (BLA) for AVT05, ...

The supplemental new drug application is based on data from the Phase 2 LITESPARK-015 trial.

Touchlight, a leader in synthetic DNA technology, has appointed Will Downie as a key adviser to support its mission of ...

Clinigen, a global specialist pharmaceutical services company, entered a strategic partnership with Tepsivo, a digital Pharmacovigilance (PV) services provider. As part of the partnership, Clinigen ...